Sanofi-Aventis CR`s Net Profit Growth reached -58.8 % in 2017. This is 59.6 % more than in the previous year.
Buy Net Profit Growth data for Sanofi-Aventis Czech Republic.
$19.99Buy all data for Sanofi-Aventis Czech Republic.
Buy annual subscriptions for all our products.
Company | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
Amgen Czech Republic | % | ... | ... | ... | ... | ... | 57.1 | -38.7 | 1.42 | 40.8 | -11.4 | |||||||
Bayer Czech Republic | % | ... | ... | ... | 39.4 | -49.7 | 15.3 | 11.2 | 15.4 | |||||||||
GlaxoSmithKline Czech Republic | % | ... | ... | ... | 45.3 | -31.8 | -22.2 | -31.2 | 42.1 | |||||||||
Merck Czech Republic | % | ... | ... | 321 | 28.7 | -56.9 | 27.5 | 96.7 | ||||||||||
Novartis Czech Republic | % | 0.860 | 19.7 | 4.60 | 57.3 | 0.548 | ||||||||||||
Pfizer Czech Republic | % | ... | ... | 137 | -79.2 | 200 | -7.25 | -43.7 | ||||||||||
Roche Czech Republic | % | ... | ... | ... | -50.1 | -23.3 | 248 | -29.6 | -46.3 | ... | ||||||||
Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 18.2 | -17.9 | 44.2 | -98.2 | 4,839 | ||||||||
Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 5.92 | 0.125 | 16.7 | ||
Walmark | % | ... | ... | ... | 63.4 | -101 | 187 | -585 | -1,813 |